Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3

Status

Completed 19Terminated 6Active not recruiting 6Recruiting 3Withdrawn 1

Sponsor Class

OTHER 6INDUSTRY 6NIH 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2Thoracic 1

Conditions

Urothelial Cancer 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 185Carboplatin 133Paclitaxel 102Cisplatin 102Gemcitabine 86Pemetrexed 80durvalumab 75Nivolumab 66Docetaxel 56atezolizumab 52Bevacizumab 50Cyclophosphamide 49Dexamethasone 45Capecitabine 45Oxaliplatin 43130-nm albumin-bound paclitaxel 42Rituximab 40Fulvestrant 39Lenalidomide 38Fluorouracil 38Prednisone 32osimertinib 31olaparib 29Leucovorin 29venetoclax 28fludarabine 28Trastuzumab 27Doxorubicin 27Etoposide 25Cetuximab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Tiragolumab × Clear all
NCT05805501 2026-05-12

A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma

Hoffmann-La Roche

Phase 2 Active not recruiting
199 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05645692 2026-04-29

A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer

Hoffmann-La Roche

Phase 2 Active not recruiting
204 enrolled
Genitourinary

Urothelial Cancer

NCT05009069 2026-04-21

A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

Hoffmann-La Roche

Phase 2 Active not recruiting
58 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04543617 2026-04-17

SKYSCRAPER-07

Hoffmann-La Roche

Phase 3 Active not recruiting
760 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04665856 2026-02-13

SKYSCRAPER-02C

Hoffmann-La Roche

Phase 3 Active not recruiting
123 enrolled 26 charts
Thoracic

Small Cell Lung Carcinoma

NCT05904886 2025-12-31

SKYSCRAPER-14

Hoffmann-La Roche

Phase 3 Active not recruiting
687 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡